Current Clinical Applications of Transthoracic Three-Dimensional Echocardiography

Badano, Luigi P.; Boccalini, Francesca; Muraru, Denisa; Bianco, Lucia Dal; Peluso, Diletta; Bellù, Roberto; Zoppellaro, Giacomo; Iliceto, Sabino

doi:10.4250/jcu.2012.20.1.1

Cited by 65 publications

(45 citation statements)

References 110 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…18,[21][22][23][24][25] This can be important in deciding whether the patient will undergo a surgical or transcatheter approach for the correction of the paravalvular regurgitation.…”

Section: Resultsmentioning

confidence: 99%

Utility of Real-Time 3-Dimensional Transesophageal Echocardiography in the Assessment of Mitral Paravalvular Leak

Arribas-Jiménez

Rama-Merchán

Barreiro-Pérez

et al. 2016

Circ J

View full text Add to dashboard Cite

“…18,[21][22][23][24][25] This can be important in deciding whether the patient will undergo a surgical or transcatheter approach for the correction of the paravalvular regurgitation.…”

Section: Resultsmentioning

confidence: 99%

Utility of Real-Time 3-Dimensional Transesophageal Echocardiography in the Assessment of Mitral Paravalvular Leak

Arribas-Jiménez

Rama-Merchán

Barreiro-Pérez

et al. 2016

Circ J

View full text Add to dashboard Cite

“…52 Its better correlation with CMR compared with the traditional 2DE in the measurement of LV volumes and LVEF was documented in a recent meta-analysis. 53 This report was derived from 23 studies that included 1174 patients in whom 2DE and 3DE performance was analyzed compared with CMR.…”

Section: Cardiac Imaging Evaluationmentioning

confidence: 97%

Diagnostic Strategies for Early Recognition of Cancer Therapeutics–Related Cardiac Dysfunction

Manrique

Park

Tiwari

et al. 2017

Clin Med Insights Cardiol

View full text Add to dashboard Cite

Cardiovascular toxicity in the form of cardiac dysfunction continues to be an obstacle for patients with cancer. Survival and quality of life of cancer survivors are frequently affected by increased incidence of cardiovascular disease. The involvement of the cardiovascular system by primary or secondary malignancies, as well as its dysfunction secondary to the administration of antineoplastics, has led to the development of a new discipline called Cardio-Oncology, an exciting cardiology subspecialty with more questions than answers and as a result an enormous opportunity for research in the field. Multidisciplinary efforts have been focused on the prevention, diagnosis, and treatment of cancer therapeutics–related cardiovascular dysfunction (CTRCD). This review article will focus on the early diagnosis of left ventricular dysfunction associated with chemotherapy. Currently, the identification of cardiac toxicity associated with cancer treatment is the cornerstone for critical decisions regarding anticancer therapy and cardioprotective strategies. Its early detection, especially in subclinical phases, allows immediate intervention to prevent further impairment of the myocardium and other cardiovascular structures. The most significant published studies were selected for this revision, providing an updated document for the health professionals involved in the care of patients with cancer. We examined the current evidence and recommendations for biochemical and noninvasive diagnostic techniques, including their specific role for identification of CTRCD. Traditional and advanced imaging modalities, used alone or in combination with cardiovascular biomarkers, are essential for the recognition of cardiotoxicity during cancer therapy. Evolving basic and clinical research are focused on the development of more sensitive and specific diagnostic tools and for the recognition of cardiac toxicity.

show abstract

“…5). 86 Advantages include better accuracy in LVEF measurements below the lower normal limits, superior reproducibility and lower temporal variability. The improved accuracy of 3D over 2D echocardiography for the detection of LVEF less than 50% was observed in survivors of childhood cancer.…”

Section: Advanced Echocardiographic Evaluationmentioning

confidence: 99%

Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity

Zito

Longobardo

Dessalvi

et al. 2016

Journal of Cardiovascular Medicine

View full text Add to dashboard Cite

The evaluation by cardiovascular imaging of chemotherapy patients became a central topic in the last several years. The use of drugs for the treatment of cancers increased, and new molecules and protocols were developed to improve outcomes in these patients. Although, these novel approaches also produced a progressive increase in side effects, particularly myocardial dysfunction. Imaging of the heart was highly accurate in the early diagnosis of cancer therapeutics related-cardiac dysfunction. Echocardiography is the first-line method to assess ventricular function alterations, and it is required to satisfy the need for an early, easy and accurate diagnosis to stratify the risk of heart failure and manage treatments. A careful monitoring of cardiac function during the course of therapy should prevent the onset of severe heart impairment. This review provides an overview of the most important findings of the role of echocardiography in the management of chemotherapy-treated patients to create a clear and complete description of the efficacy of conventional measurements, the importance of comprehensive heart evaluations, the additional role of new echocardiographic techniques, the utility of integrated studies using other imaging tools and the positions of the most important international societies on this topic.

show abstract

Current Clinical Applications of Transthoracic Three-Dimensional Echocardiography

Cited by 65 publications

References 110 publications

Utility of Real-Time 3-Dimensional Transesophageal Echocardiography in the Assessment of Mitral Paravalvular Leak

Utility of Real-Time 3-Dimensional Transesophageal Echocardiography in the Assessment of Mitral Paravalvular Leak

Diagnostic Strategies for Early Recognition of Cancer Therapeutics–Related Cardiac Dysfunction

Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity

Contact Info

Product

Resources

About